top of page

Detailed Post 

Recommendation on HMA Article 5 on unforeseen variations




Recommendation on HMA Article 5 on unforeseen variations

Art.5 on Unforeseen Variations

See guidance on when to follow an Article 5 procedure:

  • All Article 5 recommendation are published under http://www.hma.eu/293.html

  • The CMD(h) would remind applicants that the default position is a Type IB variation

  • If the specific change is not listed. Is change covered by any of the high-level scopes?

    • YES: Type IB by default, use an additional box using the sub-indent ‚z‘

    • NO: Would you recommend to classify as a Type IA?

      • NO: Submit as a Type IB by default or as a Type II (safeguard clause)

      • YES: Follow Article 5 recommendations


As a summary, Article 5 is to be followed only if change is not listed and a Type 1A would be recommended

Kommentare


logo apsyos

Our Address

Talk To our Experts

Email Us

We are located near Basel

Thanks for subscribing!

Apsyos

As Health is the main priority in our lives, it is important that patients get the most appropriate and safe treatments in the fastest and most reliable way without compromising of its quality.

About

​Apsyos offers small and medium pharmaceutical and biologic manufacturers the freedom to focus their internal capacities towards Science and Clinical Concerns by alleviating technical regulatory aspects.

We are operating from London and Basel

Map

©2021 par Apsyos. Créé avec Wix.com.

About Us   Services   Privacy

J2 RA CMC Services Ltd, 128 City Road EC1V 2NX, London, United Kingdom

Registered Company Nr: 16260386

bottom of page